✉ info@591daili.com☎ +86-18553102138
📞 WhatsAppEnglish
圣和化工
首页 › 产品目录 › 5-溴-2'-脱氧尿苷

5-溴-2'-脱氧尿苷

CAS 59-14-3C9H11BrN2O5MW 307.10

5-溴-2'-脱氧尿苷,CAS 登记号 59-14-3,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于有机化学品。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。

规格参数

CAS号59-14-3
分子式C9H11BrN2O5
分子量307.10
熔点365 to 369 °F (NTP, 1992)
LogPlog Kow = -0.29
纯度按批次COA提供(不公开发布)
包装按订单/批次确认(不公开发布)
应用领域有机化学品
类别有机化学品

用途与场景

有机化学品

包装与供货

包装规格按订单/批次确认(不公开发布)
纯度规格按批次COA提供(不公开发布)
储存条件密封、阴凉干燥处保存
供货周期现货/按订单安排

文件与支持

每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。

常见问题

在哪里能查到 5-溴-2'-脱氧尿苷 的 CAS 号?

本页已列出 5-溴-2'-脱氧尿苷 的 CAS 号:59-14-3,可与随货 COA 核对。

可以提供哪些规格和包装?

常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。

5-溴-2'-脱氧尿苷 一般用在什么产品里?

主要涉及有机化学品。

下单流程是怎样的?

来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。

PubChem 公开数据

Description

5-Bromo-2'-Deoxyuridine · CAS 59-14-3 · C9H11BrN2O5. UNII G34N38R2N1. Melting Point: 365 to 369 °F (NTP, 1992); Melting Point: 187-189 °C; Solubility: 10 to 50 mg/mL at 72 °F (NTP, 1992).

Identification

CAS Registry Number59-14-3
PubChem CID6035
Molecular formulaC9H11BrN2O5
IUPAC name5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
UNII (FDA)G34N38R2N1

Computed Descriptors

Molecular Weight307.10
XLogP3-0.3
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count5
Rotatable Bond Count2
Exact Mass305.98513
Monoisotopic Mass305.98513
Topological Polar Surface Area99.1
Heavy Atom Count17
Formal Charge0

Physical & Chemical Properties

Melting Point365 to 369 °F (NTP, 1992)
Melting Point187-189 °C
Solubility10 to 50 mg/mL at 72 °F (NTP, 1992)
SolubilityWater 10 - 20 (mg/mL)
Solubility1 N NaOH > 400 (mg/mL)
SolubilityAcetone ~ 4 (mg/mL)
LogPlog Kow = -0.29
LogP-0.29

Physical description & handling notes

  • 5-bromo-2'-deoxyuridine is a white crystalline powder. (NTP, 1992)
  • Crystals from absolute ethanol
  • Dimethylacetamide ~ 200 (mg/mL)
  • Dimethylsulfoxide ~ 160 (mg/mL)
  • Bulk: The bulk drug should be stored in tightly closed containers at controlled room temperature. Solution: BUdR solutions (0.5 and 25 mg/mL) are stable for at least seven days at room temperature.
  • (c = 1, 0.1 N NaOH) [a]20 D = +31 ± 1°

GHS Hazard Classification

Reported hazard statementsH340 (83.3%), H341 (13%), H361 (79.6%)

H340 (83.3%): May cause genetic defects [Danger Germ cell mutagenicity]

H341 (13%): Suspected of causing genetic defects [Warning Germ cell mutagenicity]

Documented Uses

  • A drug that makes cancer cells more sensitive to radiation and is also used as a diagnostic agent to determine how fast cancer cells grow.
  • A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors.
  • A thymidine analog that incorporates /into/ DNA of dividing cells during the S-phase of the cell cycle. ... However, BrdU is not a marker of the S-phase of the cell cycle. As a thymidine analog, it is a marker of DNA synthesis. BrdU immunohistochemistry has been instrumental for the study of the development of the nervous system, and to confirm that neurogenesis occurs in the adult mammalian brain, including in human. ... BrdU labeling is currently the most used technique for studying adult neurogenesis in situ.
  • The standard method for assessment of cell proliferation in paraffin-embedded tissue sections is 5-bromodeoxyuridine (BrdU) immunohistochemistry (IHC). BrdU can be administered to laboratory animals via IP injections, is readily incorporated into nuclei during the DNA synthetic phase of the cell cycle, and is detected with an anti-BrdU antibody. ...
  • Laboratory chemical used as a mutagen in mutagenesis experiments. It is more commonly used in the detection of proliferating cells in living tissues.
  • Treatment of an aqueous solution of /deoxyuridine/ with saturated bromine water at 0 °C followed by removal of excess /bromine/ by suction, concentration at 30 °C, refluxing with /ethanol/, concentration at <35 °C, and crystallization from absolute /ethanol/ gave 60% /5-bromodeoxyuridine/ (purity 99%).

Synonyms

5-BROMO-2'-DEOXYURIDINE; 59-14-3; Broxuridine; Bromodeoxyuridine; 5-Bromodeoxyuridine; BRDU; BUDR; 5-Bromo-2-deoxyuridine; Radibud; Broxuridina; 5-Bdu; 5-Bromouracil deoxyriboside; Bromouracil deoxyriboside; 5-Bromodesoxyuridine; Broxuridinum; 5-Bromouracil-2-deoxyriboside

Frequently Asked Questions

What are the CAS number and molecular formula of 5-Bromo-2'-Deoxyuridine?

CAS 59-14-3; molecular formula C9H11BrN2O5; molecular weight — g/mol.

What other names is 5-Bromo-2'-Deoxyuridine known by?

5-BROMO-2'-DEOXYURIDINE, 59-14-3, Broxuridine, Bromodeoxyuridine, 5-Bromodeoxyuridine, BRDU.

Is 5-Bromo-2'-Deoxyuridine classified as hazardous?

Hazard statements reported: H340, H341, H361.

What are the key physical properties of 5-Bromo-2'-Deoxyuridine?

Melting Point: 365 to 369 °F (NTP, 1992); Melting Point: 187-189 °C; Solubility: 10 to 50 mg/mL at 72 °F (NTP, 1992); Solubility: Water 10 - 20 (mg/mL).

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.

同类推荐

获取 5-溴-2'-脱氧尿苷 报价

供应商:济南圣和化工有限公司 · 一个工作日内回复。

邮件询价 WhatsApp
鲁ICP备19031700号-1